Meridian Medica — Oregon Grape

01

Identity

Botanical Profile

Mahonia aquifolium (Pursh) Nutt. — Root and root bark. Native to western North America, from British Columbia to northern California; naturalized in parts of Europe

Root bark: intensely bitter, yellow-orange color from berberine content. Chewing root produces a strongly bitter, slightly astringent sensation with persistent yellow staining of mouth tissues. Dried root has a faint earthy-woody aroma.

Species Integrity

Oregon grape (Mahonia aquifolium) is frequently confused with or substituted by other Mahonia/Berberis species, some of which have lower berberine content. The berberine content varies significantly between species: M. aquifolium root bark contains 3–6% berberine, while some substitutes contain less than 1%.

02

Compounds

Active Compound Profile

Berberine

3–6% in root bark; 1–3% in whole root

AMPK activator; NF-κB inhibitor; antimicrobial via DNA intercalation and FtsZ inhibition; modulates gut microbiome; inhibits CYP2D6 and CYP3A4

Berbamine

0.5–2% in root bark

Calcium channel blocker; immunomodulatory; anti-inflammatory via NF-κB pathway; antitumor activity in vitro

Oxyacanthine

0.3–1.5% in root bark

Smooth muscle relaxant; mild hypotensive; antimicrobial synergy with berberine

Jatrorrhizine

0.2–1% in root bark

Antimicrobial; anti-inflammatory; dopamine D1 receptor agonist activity; cholinesterase inhibition

Absorption

Whole-root preparations over isolated berberine: Oregon grape root contains multiple alkaloids (berbamine, oxyacanthine, jatrorrhizine) that may synergistically enhance berberine's activity and provide complementary mechanisms not present in isolated berberine supplements

03

Pathways

Mechanism of Action

★★★☆☆ AMPK / Metabolic Activation Berberine activates AMP-activated protein kinase in liver, muscle, and adipose tissue, improving insulin sensitivity, glucose uptake, and fatty acid oxidation

★★★☆☆ NF-κB / Inflammatory Cytokine Axis Berberine inhibits NF-κB activation and downstream production of TNF-α, IL-6, and IL-1β; reduces COX-2 expression

★★★☆☆ Gut Microbiome Modulation Berberine selectively inhibits pathogenic bacteria while promoting beneficial species (Akkermansia, Bifidobacterium); reduces LPS-producing gram-negative overgrowth; improves intestinal barrier function

★★★☆☆ Hepatobiliary / Bile Flow Enhancement Berberine is a cholagogue — stimulates bile production and flow; berbamine provides additional hepatoprotective activity

★★★☆☆ Antimicrobial / SIBO Management Berberine has broad-spectrum antimicrobial activity against bacteria, fungi, and protozoa; effective against common SIBO organisms including methane-producing archaea

04

Biomarkers

Documented Biomarker Effects

Biomarker	Direction	Target	Mechanism
Fasting Glucose	↓ Decrease	<100 mg/dL	AMPK activation improves hepatic glucose regulation and peripheral insulin sensitivity
HbA1c	↓ Decrease	<5.7%	Sustained glucose regulation via AMPK activation and improved insulin signaling
LDL Cholesterol	↓ Decrease	<100 mg/dL	Berberine upregulates hepatic LDL receptor expression via PCSK9 inhibition
Triglycerides	↓ Decrease	<100 mg/dL	AMPK-mediated fatty acid oxidation; improved hepatic lipid metabolism
hs-CRP	↓ Decrease	<1.0 mg/L	NF-κB inhibition reduces systemic inflammatory marker production

05

Extraction

Extraction & Preparation

Decoction (simmered 20–30 min): 60–70% berberine (as water-soluble salts); lower berbamine extraction

Solubility · Slightly soluble in water (especially as salts); soluble in ethanol and methanol; berberine sulfate and chloride forms are more water-solubleMenstruum · 60% ethanol / 40% waterPlant material · Dried Oregon grape root bark, cut and sifted or coarsely groundMaceration time · 4–6 weeks (agitate daily)Ratio · 1:5 (dried)

06

Biomarker Intel

Biomarker Intelligence

This herb has documented effects on the following markers:

Marker	Direction	Evidence	Notes
Fasting Glucose	↓ Decrease	traditional	AMPK activation improves hepatic glucose regulation and peripheral insulin sensitivity
HbA1c	↓ Decrease	traditional	Sustained glucose regulation via AMPK activation and improved insulin signaling
LDL Cholesterol	↓ Decrease	traditional	Berberine upregulates hepatic LDL receptor expression via PCSK9 inhibition
Triglycerides	↓ Decrease	traditional	AMPK-mediated fatty acid oxidation; improved hepatic lipid metabolism
hs-CRP	↓ Decrease	traditional	NF-κB inhibition reduces systemic inflammatory marker production

07

Dosing

Dosing Framework

Take Oregon grape tincture or decoction 15–20 minutes before meals for optimal bitter digestive stimulation.

Dose 1

Low / Digestive Bitter: 1–2 mL tincture before meals

The bitter taste triggers cephalic-phase digestive response; hold in mouth briefly before swallowing

Dose 2

Moderate / Antimicrobial: 2–4 mL tincture, 3x daily

Standard therapeutic range for 4–8 week antimicrobial protocols; combine with other antimicrobial herbs for SIBO

Dose 3

Higher / Metabolic: 3–5 mL tincture, 3x daily (or equivalent decoction)

Higher end of whole-root dosing; still below isolated berberine supplement doses (500mg 3x/day); monitor blood glucose if on diabetes medications

08

Synergies

Synergy Partners

★★★☆☆ Milk Thistle (Silybum marianum) Silymarin inhibits P-glycoprotein efflux of berberine, increasing systemic bioavailability 2–3x; complementary hepatoprotective action supports liver-biliary function

★★★☆☆ Dandelion Root (Taraxacum officinale) Complementary cholagogue and choleretic action; dandelion enhances bile production while berberine stimulates bile flow; synergistic hepatobiliary support

★★★☆☆ Oregano Oil (Origanum vulgare) Carvacrol and berberine target SIBO pathogens through different antimicrobial mechanisms; combination broadens antimicrobial spectrum

★★★☆☆ Ginger (Zingiber officinale) Ginger's prokinetic action complements berberine's antimicrobial action in SIBO — kill pathogens while restoring motility to prevent recurrence

Signature Stack

THE BITTER ROOTS PROTOCOL
Components: Oregon Grape (root bark) + Dandelion Root + Milk Thistle (seed) + Ginger (rhizome) · Multi-pathway convergence: Berberine antimicrobial + bile flow enhancement (Oregon grape + dandelion) + P-gp inhibition for berberine bioavailability (milk thistle) + prokinetic motility support (ginger) · The Bitter Roots Protocol targets the gut-liver-thyroid axis that is disrupted in Hashimoto's. Gut dysbiosis drives autoimmune activation; impaired bile flow reduces T4-to-T3 conversion; SIBO causes nutrient malabsorption. This stack addresses all three nodes. · Practical integration: Oregon grape and dandelion root decoction as daily pre-meal bitter tonic; milk thistle capsule with meals; ginger tea or fresh ginger in cooking throughout the day.

09

Safety

Contraindications & Interactions

Avoid Pregnancy Berberine stimulates uterine contractions and has shown embryotoxicity in animal studies. AHPA Class 2b — contraindicated in pregnancy.

Minor Lactation Berberine transfers to breast milk and has caused kernicterus-like jaundice displacement in neonatal animal models. May displace bilirubin from albumin binding sites.

Minor Drug interactions (CYP3A4 / CYP2D6) Berberine inhibits CYP3A4 and CYP2D6 enzymes and P-glycoprotein, potentially increasing blood levels of many pharmaceuticals including cyclosporine, statins, and SSRIs.

Minor Hypoglycemia risk Berberine lowers blood glucose significantly; combination with diabetes medications (metformin, sulfonylureas, insulin) may cause hypoglycemia.

Minor Long-term microbiome effects Berberine's antimicrobial activity is broad-spectrum; prolonged continuous use may deplete beneficial bacteria along with pathogens.

11

Evidence

Evidence Base

★★★★☆ Blood Glucose Regulation Strong — Multiple RCTs demonstrate efficacy comparable to metformin

★★★★☆ Lipid Profile Improvement Strong — Consistent LDL and triglyceride reduction across multiple trials

★★★☆☆ SIBO / Antimicrobial Moderate — One key RCT plus strong mechanistic data

★★★☆☆ Psoriasis (Topical) Moderate — Several controlled trials with positive results

★★★☆☆ Gut Microbiome Modulation Moderate — Emerging evidence; strong mechanistic rationale

Evidence Gaps

The whole-root alkaloid complex (berberine + berbamine + oxyacanthine + jatrorrhizine) may have synergistic effects absent from isolated berberine. A comparative trial of whole Oregon grape root tincture vs isolated berberine for SIBO eradication or metabolic markers in Hashimoto's patients would directly test the whole-plant advantage hypothesis.

Quality Alert

Oregon grape root has moderate adulteration risks:

12

Protocol

Preparation Integration

Recipe Integration

Bitter Root Digestive Tonic (signature preparation)

1/2 cup decoction before meals (~30–50mg berberine per dose)